A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.
about
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysisPatient satisfaction with specialized mental health service for obsessive-compulsive disorder.Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia.Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.Assessment and management of treatment-refractory obsessive-compulsive disorder in children.DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS.Topiramate augmentation in a patient with obsessive-compulsive disorder.Adjunctive Low-frequency Repetitive Transcranial Magnetic Stimulation over the Right Dorsolateral Prefrontal Cortex in Patients with Treatment-resistant Obsessive-compulsive Disorder: A Randomized Controlled Trial.Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Schizo-obsessive spectrum disorders: an update.Long-term electrical stimulation of bed nucleus of stria terminalis for obsessive-compulsive disorder.Lamotrigine augmentation of serotonin reuptake inhibitors in severe and long-term treatment-resistant obsessive-compulsive disorder.L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study.Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
P2860
Q21999508-C9333C73-95B4-42A8-BBAE-ADAC4533BCB8Q33643395-64F955D5-14D4-458B-9411-845D14CF5A03Q34476167-2D97ED36-BA0A-45CE-ABE4-CC06C81B5342Q35016990-993EB8F7-D7B1-4591-8651-A50E2F555DF4Q35697831-30795F92-7BD4-42DC-BA37-6C5566CDA8CBQ35889362-13A6FEE8-FDD9-4A69-9B0E-0CA003968EB9Q35976177-0018D3F4-8FEE-4FCD-B8AC-54DDF569CB6AQ36873022-9389881C-0B29-473B-AF68-3A2AB8B31364Q37245217-C0F78640-95D0-4DAA-BC30-E5C0D98C80B5Q38092129-D0AD08FE-68A0-457B-B2D9-6C1FFE2E9A5AQ38964747-824F767F-FD86-4095-996C-8D5D5498A60DQ39536844-DC41F88C-5DEA-4E95-8D1B-2A759447E40AQ41970171-FA3A1236-D89C-4BBD-9E41-C7668D7D154EQ47728541-21B4409F-4395-4271-B953-6940A68E5B70Q50665402-3CE40E0C-181D-4FDF-B2C1-211FDE4908DA
P2860
A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A 2012 evidence-based algorith ...... obsessive-compulsive disorder.
@en
type
label
A 2012 evidence-based algorith ...... obsessive-compulsive disorder.
@en
prefLabel
A 2012 evidence-based algorith ...... obsessive-compulsive disorder.
@en
P2093
P2860
P1476
A 2012 evidence-based algorith ...... obsessive-compulsive disorder.
@en
P2093
David Osser
H Blair Simpson
Hisato Matsunaga
Naomi Fineberg
Nastassja Koen
P2860
P2888
P304
P356
10.1007/S11920-012-0268-9
P407
P577
2012-06-01T00:00:00Z
P6179
1025080938